Prostatis Group LLC Johnson & Johnson Transaction History

Prostatis Group LLC

$215 Billion
Q2 2023

A detailed history of Prostatis Group LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Prostatis Group LLC holds 74,324 shares of JNJ stock, worth $12.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

74,324

Previous 5,760 1190.35%

Holding current value

$12.3 Million

Previous $902 Million 65.87%

% of portfolio

0.14%

Previous 0.48%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $10.6 Million - $11.4 Million	68,564 Added 1190.35%	74,324 $308 Million
Q1 2023 May 22, 2023	SELL	$151.05 - $180.26 $27,642 - $32,987	-183 Reduced 3.08%	5,760 $902 Million
Q4 2022 Mar 28, 2023	BUY	$160.2 - $179.79 $680,850 - $764,107	4,250 Added 251.03%	5,943 $1.05 Billion
Q4 2022 Mar 23, 2023	BUY	$160.2 - $179.79 $117 Million - $131 Million	727,863 Added 1046.4%	797,422 $1.05 Billion
Q3 2022 Mar 28, 2023	SELL	$161.33 - $179.52 $4,194 - $4,667	-26 Reduced 1.51%	1,693 $277 Million
Q3 2022 Mar 23, 2023	SELL	$161.33 - $179.52 $1.61 Million - $1.8 Million	-10,001 Reduced 12.57%	69,559 $277 Million
Q2 2022 Mar 28, 2023	BUY	$168.19 - $186.01 $46,756 - $51,710	278 Added 19.29%	1,719 $305 Million
Q2 2022 Mar 23, 2023	SELL	$168.19 - $186.01 $2.8 Million - $3.1 Million	-16,646 Reduced 17.3%	79,560 $305 Million
Q1 2022 Mar 28, 2023	SELL	$158.14 - $179.59 $24,195 - $27,477	-153 Reduced 9.6%	1,441 $255 Million
Q1 2022 Mar 23, 2023	BUY	$158.14 - $179.59 $513,480 - $583,128	3,247 Added 3.49%	96,206 $255 Million
Q4 2021 Mar 28, 2023	SELL	$155.93 - $173.01 $714,003 - $792,212	-4,579 Reduced 74.18%	1,594 $273 Million
Q4 2021 Mar 23, 2023	SELL	$155.93 - $173.01 $110 Million - $122 Million	-707,836 Reduced 88.39%	92,959 $273 Million
Q3 2021 Mar 28, 2023	BUY	$161.5 - $179.47 $84,787 - $94,221	525 Added 8.83%	6,468 $1.04 Billion
Q3 2021 Mar 23, 2023	BUY	$161.5 - $179.47 $7.83 Million - $8.7 Million	48,481 Added 6.44%	800,795 $1.04 Billion
Q2 2021 Mar 28, 2023	BUY	$159.48 - $171.07 $151,824 - $162,858	952 Added 18.23%	6,173 $1.02 Billion
Q2 2021 Mar 23, 2023	BUY	$159.48 - $171.07 $28.5 Million - $30.6 Million	179,014 Added 31.23%	752,314 $1.02 Billion
Q1 2021 Mar 28, 2023	BUY	$153.07 - $170.48 $130,568 - $145,419	853 Added 19.53%	5,221 $858 Million
Q1 2021 Mar 23, 2023	BUY	$153.07 - $170.48 $13.8 Million - $15.3 Million	89,873 Added 18.59%	573,300 $858 Million
Q4 2020 Mar 28, 2023	BUY	$137.11 - $157.38 $125,729 - $144,317	917 Added 26.57%	4,368 $687 Million
Q4 2020 Mar 23, 2023	BUY	$137.11 - $157.38 $21.5 Million - $24.6 Million	156,568 Added 47.9%	483,427 $687 Million
Q3 2020 Mar 28, 2023	BUY	$140.38 - $153.83 $122,270 - $133,985	871 Added 33.76%	3,451 $514 Million
Q3 2020 Mar 23, 2023	BUY	$140.38 - $153.83 $14.5 Million - $15.9 Million	103,377 Added 46.26%	326,859 $505 Million
Q2 2020 Mar 28, 2023	BUY	$128.81 - $155.51 $120,437 - $145,401	935 Added 56.84%	2,580 $363 Million
Q2 2020 Mar 23, 2023	BUY	$128.81 - $155.51 $12.3 Million - $14.8 Million	95,452 Added 74.55%	223,482 $363 Million
Q1 2020 Mar 28, 2023	SELL	$111.14 - $153.99 $6,779 - $9,393	-61 Reduced 3.58%	1,645 $216 Million
Q1 2020 Mar 23, 2023	SELL	$111.14 - $153.99 $2.55 Million - $3.53 Million	-22,912 Reduced 15.18%	128,030 $216 Million
Q4 2019 Mar 28, 2023	SELL	$127.5 - $146.44 $101 Million - $117 Million	-795,716 Reduced 99.79%	1,706 $249 Million
Q4 2019 Mar 23, 2023	BUY	$127.5 - $146.44 $19.2 Million - $22.1 Million	150,942 New	150,942 $249 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prostatis Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prostatis Group LLC with notifications on news.

Account

Prostatis Group LLC Johnson & Johnson Transaction History